Member Info for Laura2022

Gemrusty

Find something ?

Gemrust

See posts yesterday, had a smidgeover 375,000 before today

You ?

Purchased more at just under 5p

Good morning James

Be interesting to see how many U turns occur from the snakes

By all accounts the vipers are already turning on themselves and changing their story to suit the price action retrospectively

Funny

Toffers

Well if one was to look at the MACD and stochastic reading from early June (8p to 27p) and now

..they are almost identically oversold

Also MET1 has been tipped in a USA based Telegram group yesterday afternoon

I hadn't realised USA investors can trade MET1 but makes sense given the USA uranium interest

Morning Toffers

Auction to start , then above 6p

EAL

Good link

Only £20mln cap

In the last results they stated (see RNS)

"The cash position was bolstered in April 2025 following a retail offer and equity fundraise delivering net proceeds of £3.1 million. In April 2025, the Company issued cash warrants to the investors in the equity fundraise which are exercisable for a period of six months from the date of grant and, if exercised, would bring in up to £10 million in additional gross proceeds to the Company."

They have safe jurisdiction uranium assets bouyed by Trump energy policy

+ other gold and critical mineral assets in safe European areas like Finland

So many snakes here

He being one, simply filter but if their posts also contravene LSE posting rules ( eg abusive,personal attacks ) then report to

Info@lse.co.uk

Would be good if those intent on lies, disruption and subterfuge took Trench123 advice

Anyway..: reminder

In addition, the Company expects that £60k worth of Grant Income will be recognised in FY26.

The Company is also generating momentum across its key growth initiatives:

- Biometrics service line: June 2025 announcement of the Company's first two Biometrics contracts worth £111k and recruitment of Head of Biometrics, Jesse Thissen

- Diversification of client base: 31% of all contract awards in FY25 were from new clients, compared to 17% over the prior six years.

- Expansion into new therapeutic areas: 50% of projects delivered in FY25 were in therapeutic areas outside oncology, compared to an average of 5% over the previous three years

- Personalised Medicine - Recently announced expanded relationship with DoseMe Inc and Implementation of the Company's Dosing software onto the DoseMeRx Platform, and progress of the PREDICT-ONC trial.

 

Dr Peter Sargent, CEO of Physiomics, commented:

"I am thrilled that the changes we've made here at Physiomics are starting to have a positive effect on the Company's performance. Not only will we exceed expectations for FY25, but we've started FY26 with record levels of contracted revenue yet to be recognised and are generating significant momentum across our key growth initiativ

2 blue closes as the charts bottom ready for the big breakout

Strong buying into close

Just like with trout

I don't expect a reply as the facts are uncomfortable

Jaari888

Yes, you read it right

Losing £22mln to make £8mln revenues

:)

Jaari

You're SCE which you believe should be 10p/£200mln cap

Financial highlights

· Revenue increased by 13% to £8.2m (2023 : £7.3m), due to a 21% increase in disc sales

· Gross margin of 50% (2023 : 57%), reduction due to movement in product mix towards customers with higher future volumes

· Net research costs pre-capitalisation of £15.4m (2023 : £12.9m) due to extensive programme of initiatives to improve manufacturing efficiency and yields

· Impairment of fixed assets of £6.5m (2023 : £9.2m)

· Loss after taxation was £22.3m (2023 : £19.6m)

· Loss per share of 2.31p (2023 : 7.92p)

· Cash used in operating activities of £14.0m (2023 : £10.3m)

What have you made of

> the 10+ contracts

>1st biostatistics contracts

>trading update ahead of expectations

?

As a near TR1 holder in PYC its surprising that your only posts are to be aggressive and obnoxious to me or to criticise certain things PYC do

You're game is clear as are your lies

I'll leave that to you Trout as you have proudly claimed you were just under 3% on FAB and PYC

In fact you ridiculed my lesser holding a few months ago so I bowed to your pressure:)

Still haven't answered the questions from yesterday, simply sloped off in silence when questions get too tough

Seller nearly out

Small director buy too

Feels like big chart correction is underway

Tomorrow could be fun without good buying in the last mins

Looking strong

697k shares

Certainly looking 5.4/.5.5 toffers